BNP PARIBAS FINANCIAL MARKETS - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$252,847,000
+160.6%
12,542
+382.4%
0.00%
Q2 2021$97,032,000
-73.1%
2,600
-81.6%
0.00%
-100.0%
Q1 2021$360,972,000
-95.2%
14,117
-95.8%
0.00%
-92.9%
Q4 2020$7,467,884,000
+248.2%
338,987
+184.3%
0.01%
+366.7%
Q3 2020$2,144,804,000
+579.5%
119,222
+859.4%
0.00%
+200.0%
Q2 2020$315,646,000
-53.8%
12,427
-66.6%
0.00%0.0%
Q1 2020$682,923,000
-54.5%
37,176
-45.4%
0.00%
-66.7%
Q4 2019$1,500,243,000
+1141.5%
68,100
+709.3%
0.00%
Q3 2019$120,839,000
+28.4%
8,415
+40.9%
0.00%
Q2 2019$94,075,000
-42.5%
5,973
-46.6%
0.00%
Q1 2019$163,743,000
+639.0%
11,177
+669.8%
0.00%
Q3 2018$22,158,000
+12.6%
1,452
-9.6%
0.00%
Q2 2018$19,674,000
+6329.4%
1,606
+4918.8%
0.00%
Q1 2018$306,000
+5.9%
320.0%0.00%
Q4 2017$289,000
+57.1%
320.0%0.00%
Q3 2017$184,000
+82.2%
320.0%0.00%
Q2 2017$101,000
-7.3%
320.0%0.00%
Q1 2017$109,000
+18.5%
320.0%0.00%
Q4 2016$92,000
-99.8%
32
-99.0%
0.00%
Q4 2015$37,462,000
+46.1%
3,156
+1.0%
0.00%
Q3 2015$25,648,000
+46.4%
3,124
+148.7%
0.00%
Q2 2015$17,521,000
+885.4%
1,256
+1597.3%
0.00%
Q1 2015$1,778,000
-16.4%
74
-55.7%
0.00%
Q3 2014$2,126,000
+29.0%
167
+128.8%
0.00%
Q2 2014$1,648,000730.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders